Cat.#: ACPP-1208
| Despition | beta Catenin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1006 | Recombinant Human TNF Receptor II Protein (6×His Tag) (AC1006) | 50 µg | inquiry |
| ACPP-1543 | Human AKR1C3 Protein (AC1543) | 5 µg | inquiry |
| ACPP-1201 | HAND2 Blocking Peptide (AC1201) | 250 µg | inquiry |
| ACPP-1190 | ADCY6 Blocking Peptide (AC1190) | 250 µg | inquiry |
| ACPP-1486 | Rat VEGF C Protein (AC1486) | 2 µg | inquiry |
| ACPP-1608 | Human INHBC Protein (AC1608) | 2 µg | inquiry |
| ACPP-1503 | Human RTP4 Protein (AC1503) | 5 µg | inquiry |
| ACPP-1046 | Recombinant Mouse CD45 Protein (6×His Tag) (AC1046) | 50 µg | inquiry |
| ACPP-1432 | Human NENF Protein (AC1432) | 2 µg | inquiry |
| ACPP-1776 | Human Acrp30 Protein, HMW (AC1776) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.